FDA Orange Book
Is there a generic for Oseni?
Oseni contains alogliptin benzoate and pioglitazone. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Oseni (alogliptin benzoate and pioglitazone). The Orange Book shows its last listed patent expires June 4, 2029.
Run it in Rivvi
Map Oseni and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Oseni products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | EQ 12.5MG BASE;EQ 15MG BASE | Discontinued | None | 0 | None |
| tablet, oral | EQ 12.5MG BASE;EQ 30MG BASE | Marketed (Rx) | None | 0 | None |
| tablet, oral | EQ 12.5MG BASE;EQ 45MG BASE | Discontinued | None | 0 | None |
| tablet, oral | EQ 25MG BASE;EQ 15MG BASE | Marketed (Rx) | None | 0 | None |
| tablet, oral | EQ 25MG BASE;EQ 30MG BASE | Marketed (Rx) | None | 0 | None |
| tablet, oral | EQ 25MG BASE;EQ 45MG BASE | Marketed (Rx) | None | 0 | None |
NDA 022426, held by TAKEDA PHARMACEUTICALS USA INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Oseni patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 7807689 | June 27, 2028 | Drug substance, Drug product | U-1337 | 022426 |
| 8637079 | June 4, 2029 | Drug product | None | 022426 |
Oseni NDC codes
Questions
Is there a generic for Oseni?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Oseni (alogliptin benzoate and pioglitazone). The Orange Book shows its last listed patent expires June 4, 2029.
What is the generic name for Oseni?
The active ingredient in Oseni is alogliptin benzoate and pioglitazone, per the FDA Orange Book.
When does the Oseni patent expire?
The last patent listed for Oseni in the Orange Book expires June 4, 2029. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Oseni and Alogliptin Benzoate and Pioglitazone
- Dipeptidyl Peptidase 4 Inhibitors listFDA drug class
- Peroxisome Proliferator Receptor alpha Agonists listFDA drug class
- Peroxisome Proliferator Receptor gamma Agonists listFDA drug class
- Thiazolidinediones listFDA drug class
- NDC 64764-123Oseni NDC record
- NDC 64764-251Oseni NDC record
- NDC 64764-253Oseni NDC record